3-Hydroxy-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-ones as new HIV-1 integrase inhibitors WO2011046873 A1.

about

3-Hydroxy-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-ones as new HIV-1 integrase inhibitors WO2011046873 A1.

Item

http://www.wikidata.org/entity/Q44755786

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

3-Hydroxy-6,7-dihydropyrimido[ ...... se inhibitors WO2011046873 A1.

@en

3-Hydroxy-6,7-dihydropyrimido[ ...... se inhibitors WO2011046873 A1.

@nl

type

Item

label

3-Hydroxy-6,7-dihydropyrimido[ ...... se inhibitors WO2011046873 A1.

@en

3-Hydroxy-6,7-dihydropyrimido[ ...... se inhibitors WO2011046873 A1.

@nl

prefLabel

3-Hydroxy-6,7-dihydropyrimido[ ...... se inhibitors WO2011046873 A1.

@en

3-Hydroxy-6,7-dihydropyrimido[ ...... se inhibitors WO2011046873 A1.

@nl

P1476

3-Hydroxy-6,7-dihydropyrimido[ ...... se inhibitors WO2011046873 A1.

@en

P2093

Philippe Cotelle

http://www.w3.org/2001/XMLSchema#string

P2860

Retroviral intasome assembly and inhibition of DNA strand transfer

Raltegravir with optimized background therapy for resistant HIV-1 infection

5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice - clinical sciences

Pharmacokinetics and safety of S/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers.

New first and second generation inhibitors of human immunodeficiency virus-1 integrase.

Potential for new antiretrovirals to address unmet needs in the management of HIV-1 infection.

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors.

The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral

In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor.

Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients--impact of HIV subtypes and prior raltegravir experience.

P304

1799-1804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.2011.624272

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21974685

http://www.w3.org/2001/XMLSchema#string